Credin, France

Anne-Laure Blayo

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Anne-Laure Blayo

Introduction

Anne-Laure Blayo is a prominent inventor based in Credin, France. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds with therapeutic applications. With a total of two patents to her name, her work focuses on innovative solutions for various medical conditions.

Latest Patents

Anne-Laure Blayo's latest patents include the development of 5-azaindazole derivatives as adenosine receptor antagonists. This invention relates to novel compounds that have been found to be highly effective in treating hyperproliferative or infectious diseases. The 5-azaindazole derivatives can be utilized as therapeutic agents, showcasing their potential in pharmaceutical compositions. Another significant patent involves triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists. These compounds are designed to address various physiological and pathophysiological conditions mediated by growth hormone secretagogue receptors, offering potential treatments for issues such as obesity, diabetes, and inflammation.

Career Highlights

Throughout her career, Anne-Laure Blayo has worked with notable companies in the pharmaceutical industry, including Merck Patent GmbH and Aeterna Zentaris GmbH. Her experience in these organizations has contributed to her expertise in patent development and innovation in drug design.

Collaborations

Anne-Laure has collaborated with talented individuals such as Baptiste Manteau and Camille Amalric. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Anne-Laure Blayo's contributions to the field of pharmaceuticals through her innovative patents demonstrate her commitment to advancing medical science. Her work not only addresses critical health issues but also showcases the importance of collaboration in the innovation process.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…